Abstract |
In this study, we investigated the antitumor activity of axitinib, a selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases, against melanoma cells. Axitinib dose-dependently inhibited the proliferation and induced the apoptosis of B16F1 cells in vitro. In a mouse model of melanoma xenograft, axitinib significantly suppressed tumor growth and induced apoptosis of cells in tumor tissues at a dose of 25 mg/kg. In addition, axitinib suppressed the lung metastasis of melanoma cells and prolonged the life span of tumor-bearing mice. Axitinib also enhanced the proportion of CD8⁺ T cells and reduced the proportion of myeloid-derived suppressor cells in CD45.2⁺ cells, whereas the proportions of CD4⁺ T cells and Treg cells were not affected. The mRNA expressions of inducible nitric oxide synthases-2 and arginase-1, which were associated with the function of myeloid-derived suppressor cells in tumor tissues, were inhibited by axitinib. Moreover, axitinib suppressed the expressions of proinflammatory cytokines such as IL-6, TNF-α, and IFN-γ. Altogether, our results showed the unique antitumor mechanism of axitinib and provided useful information for its clinical application.
|
Authors | Xiaohua Zhang, Xianying Fang, Zhenzhen Gao, Wei Chen, Feifei Tao, Peifen Cai, Huaqin Yuan, Yongqian Shu, Qiang Xu, Yang Sun, Yanhong Gu |
Journal | Anti-cancer drugs
(Anticancer Drugs)
Vol. 25
Issue 2
Pg. 204-11
(Feb 2014)
ISSN: 1473-5741 [Electronic] England |
PMID | 24135499
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Imidazoles
- Indazoles
- Axitinib
- FLT1 protein, human
- Vascular Endothelial Growth Factor Receptor-1
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Axitinib
- Cell Proliferation
(drug effects)
- Female
- Humans
- Imidazoles
(pharmacology)
- Indazoles
(pharmacology)
- Lung Neoplasms
(prevention & control, secondary)
- Melanoma, Experimental
(drug therapy, immunology, pathology)
- Mice
- Mice, Inbred C57BL
- Neovascularization, Pathologic
(prevention & control)
- Tumor Microenvironment
(drug effects, immunology)
- Vascular Endothelial Growth Factor Receptor-1
(antagonists & inhibitors, physiology)
- Xenograft Model Antitumor Assays
|